Laboratory Development of a Self-Powered FONTAN for Treatment of Congenital Heart Disease

A Das - 2016 - commons.erau.edu
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …

Laboratory Development of a Self-Powered FONTAN for Treatment of Congenital Heart Disease

A Das, A Khoury, J Tibbets, EA Divo, AJ Kassab… - ASTFE Digital …, 2017 - dl.astfe.org
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …

[PDF][PDF] Laboratory Development of a Self-Powered Fontan for Treatment of Congenital Heart Disease

A Das - 2016 - pdfs.semanticscholar.org
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …

[PDF][PDF] Laboratory Development of a Self-Powered Fontan for Treatment of Congenital Heart Disease

A Das - 2016 - commons.erau.edu
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …

[PDF][PDF] Laboratory Development of a Self-Powered Fontan for Treatment of Congenital Heart Disease

A Das - 2016 - scholar.archive.org
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …

[PDF][PDF] Laboratory Development of a Self-Powered Fontan for Treatment of Congenital Heart Disease

A Das - 2016 - core.ac.uk
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …

[PDF][PDF] Laboratory Development of a Self-Powered Fontan for Treatment of Congenital Heart Disease

A Das - 2016 - academia.edu
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …

Laboratory Development of a Self-Powered FONTAN for Treatment of Congenital Heart Disease

A Das, A Khoury, J Tibbets, EA Divo, AJ Kassab… - ASTFE Digital …, 2017 - dl.astfe.org
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …

Laboratory Development of a Self-Powered FONTAN for Treatment of Congenital Heart Disease

A Das, A Khoury, J Tibbets, E Divo, AJ Kassab… - ASTFE Digital …, 2017 - dl.astfe.org
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …

[PDF][PDF] Laboratory Development of a Self-Powered Fontan for Treatment of Congenital Heart Disease

A Das - 2016 - academia.edu
Around 8% of all newborns with a Congenital Heart Defect (CHD) have only a single
functioning ventricle. The Fontan operation has served as a palliation for this anomaly for …